Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	12.60	127.31	113.06
Graham Fair Price	0.86	27.91	27.68
PEG	425.64	-11.48	2.18
Price/Book	23.15	6.53	5.30
Price/Cash Flow	-44.91	91.23	165.60
Prices/Earnings	34.13	35.07	26.14
Price/Sales	22.94	36.46	29.66
Price/FCF	-44.91	91.23	165.60
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	6.48	0.59	0.55
Operating Margin	4.66	0.26	0.25
ROA	-7.71	0.03	0.03
ROE	0.05	0.05	-8.19
ROIC	0.03	0.03	-2.47
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.01	-48.97
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.01	0.11	642.67
EPS QOQ	0.12	-0.03	-74.48
FCF QOQ	-0.44	1.36	206.65
Revenue QOQ	0.04	0.06	34.42
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	206.58	228.20	10.46
Days Sales Outstanding (DSO)	74.60	63.09	-15.44
Inventory Turnover	0.44	0.39	-9.47
Debt/Capitalization	0.25	0.23	-4.34
Quick Ratio	1.72	1.76	2.28
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	25.91	27.27	5.27
Cash	15.31	17.07	11.48
Capex	-0.25	-0.10	62.15
Free Cash Flow	0.83	1.95	135.29
Revenue	4.63	4.88	5.45
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.20	2.26	2.56
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	3.75	3.00	-20.00
Naive Interpretation	Member

06 - Financial Health · Bad

Rating